315 related articles for article (PubMed ID: 33677228)
21. Protective role of G-CSF in dextran sulfate sodium-induced acute colitis through generating gut-homing macrophages.
Meshkibaf S; Martins AJ; Henry GT; Kim SO
Cytokine; 2016 Feb; 78():69-78. PubMed ID: 26687628
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines.
Noda I; Fujieda S; Ohtsubo T; Tsuzuki H; Tanaka N; Sunaga H; Saito H
Int J Cancer; 1999 Jan; 80(1):78-84. PubMed ID: 9935235
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotection through G-CSF: recent advances and future viewpoints.
Rahi V; Jamwal S; Kumar P
Pharmacol Rep; 2021 Apr; 73(2):372-385. PubMed ID: 33389706
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory effects of G-CSF in cancer: Therapeutic implications.
Mouchemore KA; Anderson RL
Semin Immunol; 2021 Apr; 54():101512. PubMed ID: 34763974
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells.
Wang J; Yao L; Zhao S; Zhang X; Yin J; Zhang Y; Chen X; Gao M; Ling EA; Hao A; Li G
Cancer Biol Ther; 2012 Apr; 13(6):389-400. PubMed ID: 22313638
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience.
Li L; Yin J; Li Y; Wang C; Mao X; Wei J; Cao Y; Wang N; Lin L; Xu J; Zhang Y
Front Immunol; 2021; 12():621935. PubMed ID: 33912154
[TBL] [Abstract][Full Text] [Related]
27. G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers.
Li W; Zhang X; Chen Y; Xie Y; Liu J; Feng Q; Wang Y; Yuan W; Ma J
Protein Cell; 2016 Feb; 7(2):130-40. PubMed ID: 26797765
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte-colony-stimulating factor stimulation of bone marrow mesenchymal stromal cells promotes CD34+ cell migration via a matrix metalloproteinase-2-dependent mechanism.
Ponte AL; Ribeiro-Fleury T; Chabot V; Gouilleux F; Langonné A; Hérault O; Charbord P; Domenech J
Stem Cells Dev; 2012 Nov; 21(17):3162-72. PubMed ID: 22651889
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
[TBL] [Abstract][Full Text] [Related]
30. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
McLemore ML; Poursine-Laurent J; Link DC
J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells.
Sugimoto C; Fujieda S; Sunaga H; Noda I; Tanaka N; Kimura Y; Saito H; Matsukawa S
Int J Cancer; 2001 Jul; 93(1):42-6. PubMed ID: 11391619
[TBL] [Abstract][Full Text] [Related]
32. Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer.
Theron AJ; Steel HC; Rapoport BL; Anderson R
Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33233675
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells.
Herbert KE; Walkley CR; Winkler IG; Hendy J; Olsen GH; Yuan YD; Chandraratna RA; Prince HM; Lévesque JP; Purton LE
Transplantation; 2007 Feb; 83(4):375-84. PubMed ID: 17318068
[TBL] [Abstract][Full Text] [Related]
34. The importance of the granulocyte-colony stimulating factor in oncology.
Cetean S; Căinap C; Constantin AM; Căinap S; Gherman A; Oprean L; Hangan A; Oprean R
Clujul Med; 2015; 88(4):468-72. PubMed ID: 26732055
[TBL] [Abstract][Full Text] [Related]
35. Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia.
Inukai T; Sugita K; Mitsui K; Iijima K; Goi K; Tezuka T; Kojika S; Kagami K; Mori T; Kinoshita A; Suzuki T; Okazaki-Koyama T; Nakazawa S
Leukemia; 2000 Aug; 14(8):1386-95. PubMed ID: 10942233
[TBL] [Abstract][Full Text] [Related]
36. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression.
Mueller MM; Herold-Mende CC; Riede D; Lange M; Steiner HH; Fusenig NE
Am J Pathol; 1999 Nov; 155(5):1557-67. PubMed ID: 10550313
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform.
White SM; Alarcon MH; Tweardy DJ
Blood; 2000 Jun; 95(11):3335-40. PubMed ID: 10828013
[TBL] [Abstract][Full Text] [Related]
38. G-CSF and its receptor in myeloid malignancy.
Beekman R; Touw IP
Blood; 2010 Jun; 115(25):5131-6. PubMed ID: 20237318
[TBL] [Abstract][Full Text] [Related]
39. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
Ward AC; van Aesch YM; Gits J; Schelen AM; de Koning JP; van Leeuwen D; Freedman MH; Touw IP
J Exp Med; 1999 Aug; 190(4):497-507. PubMed ID: 10449521
[TBL] [Abstract][Full Text] [Related]
40. Stat3 and G-CSF-induced myeloid differentiation.
Chakraborty A; Tweardy DJ
Leuk Lymphoma; 1998 Aug; 30(5-6):433-42. PubMed ID: 9711905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
